Jan Dürig Selected Research

Jan Dürig Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 02/2005
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2004
9	Multiple Myeloma 01/2022 - 10/2017
5	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 09/2009
5	Disease Progression 01/2017 - 04/2003
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2019 - 10/2018
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2019 - 09/2009
3	Lymphoma (Lymphomas) 04/2019 - 09/2010
3	Infections 10/2018 - 02/2005
2	Residual Neoplasm 01/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 12/2017
2	Fever (Fevers) 12/2017 - 01/2010
2	Anemia 01/2016 - 06/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 12/2020
1	Second Primary Neoplasms (Neoplasms, Second) 10/2018
1	Cryoglobulinemia 01/2018
1	Trisomy (Trisomies) 01/2018
1	Aspergillosis 12/2017
1	Mycoses (Diseases, Fungus) 12/2017
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2017
1	Monoclonal Gammopathy of Undetermined Significance 11/2017
1	Testicular Neoplasms (Testicular Cancer) 10/2017
1	Lymphadenopathy 01/2017
1	Dementia (Dementias) 01/2016
1	Folic Acid Deficiency (Folic Acid Deficiencies) 06/2013
1	Iron Deficiencies 06/2013
1	Chronic Disease (Chronic Diseases) 06/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Carcinogenesis 01/2013
1	Vascular Remodeling 03/2012
1	Neoplasm Metastasis (Metastasis) 03/2012
1	Carcinoma (Carcinomatosis) 03/2012

Drug/Important Bio-Agent (IBA)

5	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2016
5	Rituximab (Mabthera)FDA Link 09/2021 - 10/2018
4	Bortezomib (Velcade)FDA Link 01/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2004
3	obinutuzumabIBA 01/2022 - 10/2018
3	ibrutinibIBA 01/2022 - 01/2021
3	ofatumumab FDA Link 01/2021 - 06/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 09/2010
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2021
2	pomalidomideIBA 01/2022 - 01/2021
2	Bendamustine Hydrochloride FDA Link 01/2021 - 10/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 10/2018
2	Prednisone (Sone)FDA LinkGeneric 04/2019 - 10/2018
2	Vincristine (Oncovin)FDA LinkGeneric 04/2019 - 10/2018
2	AntigensIBA 10/2017 - 09/2004
2	fludarabineIBA 01/2017 - 06/2011
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 06/2013
2	Messenger RNA (mRNA)IBA 09/2012 - 12/2009
2	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 04/2004
1	MicroRNAs (MicroRNA)IBA 01/2022
1	venetoclaxIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2021
1	Interferon-alpha (Interferon Alfa)IBA 09/2021
1	Melphalan (Alkeran)FDA LinkGeneric 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Alemtuzumab (Campath)FDA Link 12/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	GalliumIBA 10/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018
1	Cyclin-Dependent Kinase 9IBA 05/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	liposomal amphotericin B FDA Link 12/2017
1	Inosine Triphosphate (ITP)IBA 12/2017
1	Voriconazole (Vfend)FDA LinkGeneric 12/2017
1	Nitrogen DioxideIBA 11/2017
1	Particulate MatterIBA 11/2017
1	CytokinesIBA 07/2017
1	B7-H1 AntigenIBA 07/2017
1	InterferonsIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Thymidine KinaseIBA 01/2017
1	C-Reactive ProteinIBA 06/2013
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 06/2013
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 05/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2013
1	Hyaluronic Acid (Hyaluronan)IBA 05/2013
1	LigandsIBA 05/2013
1	Protein Kinase CIBA 01/2013
1	ProgranulinsIBA 01/2013
1	GranulinsIBA 01/2013

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2010
7	Drug Therapy (Chemotherapy) 09/2021 - 04/2003
3	Stem Cell Transplantation 09/2021 - 01/2021
2	Radiotherapy 08/2019 - 12/2018
1	Immunotherapy 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2020
1	Activities of Daily Living (ADL) 01/2016
1	Heterologous Transplantation (Xenotransplantation) 03/2012